We're rewriting the human genome. Are you the scientist who helps us get there?
Micro CRISPR isn't a startup with a slide deck and a dream. We're a clinical-stage synthetic biology company with proven depth — building living therapeutics for cancer, neurodegeneration, and rare genetic disorders.
The numbers speak for themselves: 3+ years of innovation · 2 clinical-stage assets · 30+ programs in pipeline 700+ employees · 400+ R&D scientists (80+ top-tier PhDs) · 75+ patents filed 15+ AI-generated products in pipeline · Backed by Bilakhia Holdings
Our Technology Stack — R&D Powerhouse Across 6 Modalities
We don't bet on one platform. We command all of them:
⚙️ Cell Therapy — Advanced CAR-T & MyCART programs engineering living cells to eliminate disease ✂️ Gene Editing — Proprietary CRISPR for single-dose curative therapies via precise genomic correction RNA Therapeutics — mRNA, siRNA & ASO-based modalities for versatile therapeutic targeting Gene Delivery — AAV, LVV, LNPs & GalNAc vectors for safe, efficient in vivo delivery AI-Guided Biologics — AI-accelerated discovery of novel antibodies and peptides AI-Designed Small Molecules — Next-gen small molecule discovery powered by machine intelligence
All modalities. One coordinated R&D stack. Zero silos.
For US-Based Scientific Consultants
Attending ASGCT 2026 in Boston? Let’s talk.
I’m heading to Boston (May 8–15) representing Micro CRISPR — a Bilakhia Holdings company building programmable genetic medicines across CRISPR, AAV ,mRNA, CAR-T, and AI-guided drug discovery. We’re based in Vapi, India, but our science has no borders.
We are actively looking for US-based Scientific Consultants — people who want to stay where they are and still make a global impact in gene editing.
What’s on the table:
• Remote / Flexible consulting engagement
• Roles in: Research Strategy | BD | Regulatory Advisory | IP & Licensing | Computational Science
• Work with a lean, ambitious team on real-world Cell and Gene Therapy platforms
• Competitive consulting compensation.
• Long-term relationship with a clinical-stage company scaling fast
Open consulting roles:
• AI / Computational Scientist — Drug Discovery & Genomics (Remote-first)
• Research Strategy Advisor — Molecular Biology & Cell Biology - Cell and Gene Therapy
• Regulatory & IP Advisory — Cell and Gene Therapy
• Process Development Consultant — USP/DSP, LNP, mRNA .
If you’re a researcher, scientist, or industry professional attending ASGCT — I’d love to grab 15 minutes in Boston. DM me here or email
[email protected]
(Subject: Consultant — ASGCT 2026 Meeting).
microcrispr.com .
Rolling applications — early candidates receive priority consideration.